Nurix Therapeutics Announces IND clearance for DeTIL-0255, a drug-enhanced autologous T cell therapy for the potential treatment of a variety of solid tumors Portfolio News / By Karina Tin November 12, 2021 Nurix Therapeutics Announces IND clearance for DeTIL-0255, a drug-enhanced autologous T cell therapy for the potential treatment of a variety of solid tumors Read More »
A2 Bio Provides First Preclinical Data Presentation for CEA and MSLN Programs, Including Trial Update at SITC 2021 Portfolio News / By Karina Tin November 12, 2021 A2 Bio Provides First Preclinical Data Presentation for CEA and MSLN Programs, Including Trial Update at SITC 2021 Read More »
RAPT Therapeutics Reports Third Quarter 2021 Financial Results Portfolio News / By Karina Tin November 10, 2021 RAPT Therapeutics Reports Third Quarter 2021 Financial Results Read More »
Tenaya Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Updates Portfolio News / By Karina Tin November 10, 2021 Tenaya Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Updates Read More »
Revolution Medicines Reports Third Quarter Financial Results and Update on Corporate Progress Portfolio News / By Karina Tin November 10, 2021 Revolution Medicines Reports Third Quarter Financial Results and Update on Corporate Progress Read More »
eFFECTOR Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update Portfolio News / By Karina Tin November 8, 2021 eFFECTOR Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update Read More »
ORIC Pharmaceuticals Reports Third Quarter 2021 Financial Results and Operational Update Portfolio News / By Karina Tin November 8, 2021 ORIC Pharmaceuticals Reports Third Quarter 2021 Financial Results and Operational Update Read More »
Neurona Therapeutics Presents Preclinical Data from Lead Cell Therapy Candidate NRTX-1001 at Neuroscience 2021 Portfolio News / By Karina Tin November 8, 2021 Neurona Therapeutics Presents Preclinical Data from Lead Cell Therapy Candidate NRTX-1001 at Neuroscience 2021 Read More »
NGM Bio Provides Business Highlights and Reports Third Quarter 2021 Financial Results Portfolio News / By Karina Tin November 4, 2021 NGM Bio Provides Business Highlights and Reports Third Quarter 2021 Financial Results Read More »
ORIC Pharmaceuticals to Present Update on CD73 Inhibitor Program in Multiple Myeloma at the American Society of Hematology (ASH) Annual Meeting Portfolio News / By Karina Tin November 4, 2021 ORIC Pharmaceuticals to Present Update on CD73 Inhibitor Program in Multiple Myeloma at the American Society of Hematology (ASH) Annual Meeting Read More »
